XML 25 R14.htm IDEA: XBRL DOCUMENT v3.26.3
Segment Reporting
9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Segment Reporting Segment Reporting
Operating segments are defined as components of an entity about which discrete financial information is evaluated regularly by the Company's Chief Operating Decision Maker ("CODM") in deciding how to allocate resources and assess performance. Rockwell operates in one market segment, the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including dialysis concentrates and other ancillary products used in the dialysis process. Accordingly, the Company has one reportable segment. The Company has a single management team that reports to its Chief Executive Officer, the Company's CODM, who comprehensively manages the entire Company. The accounting policies of the segment are the same as those described in the summary of significant accounting policies.

The CODM assesses performance for the segment and decides how to allocate resources based on net loss that also is reported on the statements of operations and comprehensive loss as net loss. The CODM uses net loss to monitor budget and forecast versus actual results in assessing segment performance, as well as cash forecast models, in order to evaluate operating results and performance in deciding how to allocate resources. The measure of segment assets is reported on the condensed consolidated balance sheets as total assets.

The Company’s significant segment expenses for its one segment for the three and nine months ended September 30, 2026 and 2025 consisted of the following (table in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net Sales$19,122 $15,927 $54,238 $50,912 
Cost of Sales16,011 13,655 44,987 43,095 
Gross Profit3,111 2,272 9,251 7,817 
Employee Compensation2,665 2,539 7,875 7,598 
Administrative Costs1,820 1,317 5,291 4,512 
Transaction-related expenses847 — 847 — 
Operating Loss(2,221)(1,584)(4,762)(4,293)
Other Income (Expense):
Realized Gain on Available-for-Sale Investments128 61 378 181 
Interest Expense(282)(285)(845)(838)
Interest Income51 55 128 190 
Total Other Expense, net(103)(169)(339)(467)
Net Loss$(2,324)$(1,753)$(5,101)$(4,760)